Nirmidas gets FDA EUA for Covid-19 rapid antibody fingerstick test
Nirmidas Biotech has secured the US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its Covid-19 rapid antibody IgG/IgM test. The Covid-19 rapid antibody IgG/IgM test,